PharmaShots Weekly Snapshot (August 19 – 23, 2019)

  1. OxThera’s Oxabact Receives EMA’s Positive Decision on Pediatric Investigational Plan to Treat Primary Hyperoxaluria

Published: Aug 23, 2019 | Tags: OxThera, Oxabact, Receives, EMA, Positive Decision, Pediatric Investigational Plan, Treat, Primary Hyperoxaluria

2.Novartis Signs an Option Agreement with Iconic Therapeutics for its Ophthalmology Program

Published: Aug 22, 2019 | Tags: Novartis, Signs, Option Agreement, Iconic Therapeutics, Ophthalmology Program

3.Roche’s Tecentriq (atezolizumab) Receives MHLW’s Approval as the First Immunotherapy for Extensive-Stage Small Cell Lung Cancer in Japan

Published: Aug 22, 2019 | Tags: Roche, Tecentriq, atezolizumab, Receives, MHLW, Approval, First, Immunotherapy, Extensive-Stage Small Cell Lung Cancer, Japan

4.Cantargia Extends its Licensing Agreement with BioWa for its POTELLIGENT Technology

Published: Aug 23, 2019 | Tags: Cantargia, Extends, Licensing Agreement, BioWa, POTELLIGENT Technology

5.Amgen and Allergan Report Results of ABP 798 (biosimilar, rituximab) in JASMINE Study for Non-Hodgkin’s Lymphoma

Published: Aug 23, 2019 | Tags: Amgen, Allergan, Report, Results, ABP 798, biosimilar, rituximab, JASMINE, Study, Non-Hodgkin’s Lymphoma

6.MSD Signs an Exclusive License and Research Agreement with Themis Bioscience to Develop Vaccine Therapies

Published: Aug 22, 2019 | Tags: MSD, Signs, Exclusive, License, Research, Agreement, Themis Bioscience, Develop, Vaccine Therapies

7.AstraZeneca Signs an Agreement with Sobi to Buy its Priority Review Voucher for $95M

Published:  Aug 22, 2019 | Tags:  AstraZeneca, Agreement, Sobi, Buy, Priority Review Voucher, $95M

8.Innovent Signs a License Agreement with Eli Lilly to Develop and Commercialize OXM3 in China

Published: Aug 22, 2019 | Tags: Innovent, Signs, License, Agreement, Eli Lilly, Develop, Commercialize, OXM3, China

9.AstraZeneca and FibroGen’s Roxadustat Receive NMPA’s Approval for the Treatment of Anemia in Non-Dialysis-Dependent Patients with Chronic Kidney Disease in China

Published: Aug 22, 2019 | Tags: AstraZeneca, FibroGen, Roxadustat, Receives, NMPA, Approval, Anemia, Non-Dialysis-Dependent, Chronic Kidney Disease, China

10.Biocon Receives EU’s GMP Certification for its Semglee (biosimilar, Insulin Glargine) Manufacturing Facility in Malaysia

Published: Aug 22, 2019 | Tags: Biocon, Semglee, biosimilar, Insulin Glargine, Manufacturing Facility, Receives, EU, GMP, Certification, Malaysia

11.Janssen’s Darzalex (daratumumab) Receives MHLW’s Approval for Transplant Ineligible Patients with Multiple Myeloma in Japan

Published: Aug 22, 2019 | Tags: Janssen, Darzalex, daratumumab, Receives, MHLW, Approval, Transplant Ineligible Patients, Multiple Myeloma, Japan

12.Pfizer to Invest $500M in State-of-the-Art Gene Therapy Facility in North Carolina

Published: Aug 21, 2019 | Tags: Pfizer, Invest, $500M, state-of-the-art Gene Therapy, Facility, North Carolina

13.Orexo Enters into an Agreement with GAIA to Develop and Commercialize Digital Therapy for Opioid Use Disorder

Published: Aug 20, 2019 | Tags: Orexo, Enters, Agreement, GAIA, Develop, Commercialize, Digital Therapy, Opioid Use Disorder

14.BioInvent to Initiate P-I/IIa Study with BI-1206 in Combination with Merck’s Keytruda (pembrolizumab) for Solid Tumors

Published: Aug 21, 2019 | Tags: BioInvent, Initiate, P-I/IIa, Study, BI-1206, Merck, Keytruda, pembrolizumab, Solid Tumors

15.GSK Reports Submission of NDA to MHLW for Daprodustat to Treat Patients with Renal Anaemia due to Chronic Kidney Disease in Japan

Published: Aug 21, 2019 | Tags: GSK, Reports, Submission, NDA, MHLW, Daprodustat, Renal Anaemia, Chronic Kidney Disease, Japan

16.AstraZeneca Reports Results of Imfinzi (durvalumab) + Tremelimumab in P-III NEPTUNE Study for Stage IV Non-Small Cell Lung Cancer

Published: Aug 21, 2019 | Tags: AstraZeneca, Reports, Results, Imfinzi, durvalumab, Tremelimumab, P-III, NEPTUNE, Study, Stage IV, Non-Small Cell Lung Cancer

17.Vivus Reports Results of Qsymia in Pilot Clinical Study for Patients with Laparoscopic Sleeve Gastrectomy Surgery

Published: Aug 20, 2019 | Tags: Vivus, Reports, Results, Qsymia, Pilot Clinical Study, Patients, Laparoscopic Sleeve Gastrectomy Surgery

18.Biotheus Enters into an Agreement with Alligator Bioscience to Develop Bispecific Molecules in Greater China

Published: Aug 20, 2019 | Tags: Biotheus, Enters, Antibody, Agreement, Alligator Bioscience, Greater China

19. Gedeon Richter Launches Terrosa (biosimilar, teriparatide) in Europe

Published: Aug 20, 2019 | Tags: Gedeon Richter, Launches, Terrosa, biosimilar, teriparatide, Europe

20.Elanco To Acquire Bayer’s Animal Health Business for $7.6B

Published: Aug 20, 2019 | Tags: Elanco, Acquire, Bayer, Animal Health Business, $7.6B

21.Nabriva’s Xenleta (lefamulin) Receives FDA’s Approval for the Treatment of Community-Acquired Bacterial Pneumonia in Adults

Published: Aug 19, 2019 | Tags: Nabriva, Xenleta, lefamulin, Receives, FDA, Approval, Treatment, Community Acquired Bacterial Pneumonia, Adults

22.AstraZeneca Reports Results of Farxiga (dapagliflozin) in P-III DAPA-HF Study to Treat Patients with Heart Failure

Published: Aug 20, 2019 | Tags: AstraZeneca, Reports, Results, Farxiga, dapagliflozin, P-III, DAPA-HF, Study, Treat, Patients, Heart Failure

23.Boston Scientific’s ImageReady MRI For Vercise Gevia Deep Brain Stimulation System Receives FDA’s Approval for Parkinson’s Disease

Published: Aug 20, 2019 | Tags: Boston Scientific, ImageReady MRI, Vercise Gevia, Deep Brain Stimulation System, Receives, FDA, Approval, Parkinson’s Disease

24.Dr. Reddy’s Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancer Indications in India

Published: Aug 19, 2019 | Tags: Dr. Reddy’s Laboratories, Launches, Versavo, biosimilar, bevacizumab, Cancers, India

25.Glenmark’s Combination Therapy of Remogliflozin Etabonate + Metformin Hydrochloride Receive Approval for Type 2 Diabetes in India

Published: Aug 19, 2019 | Tags: Glenmark, Combination Therapy, Remogliflozin Etabonate, Metformin Hydrochloride, Receive, Approval, Type 2 Diabetes, India

26.CVRx’s Barostim Neo Device Receives the US FDA’s Approval as World’s First Heart Failure Neuromodulation Device

Published: Aug 16, 2019 | Tags: CVRx, Barostim Neo, Device, Receives, US, FDA, Approval, World, First, Heart Failure Neuromodulation Device

27.Alcon to Launch PRECISION1 Daily Disposable Contact Lenses in the US

Published: Aug 19, 2019 | Tags: Alcon, Launch, PRECISION1, Daily, Disposable, Contact Lenses, US

28.Celgene’s Inrebic (fedratinib) Receives the US FDA’s Approval for Myelofibrosis

Published: Aug 16, 2019 | Tags: Celgene, Inrebic, fedratinib, Receives, US, FDA, Approval, Myelofibrosis

29.AbbVie’s Rinvoq (upadacitinib) Receives the US FDA’s Approval for Moderate to Severe Rheumatoid Arthritis

Published: Aug 06, 2019 | Tags: AbbVie, Rinvoq, upadacitinib, Receives, US, FDA, Approval, Moderate, Severe, Rheumatoid Arthritis

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post